LONDON: The UK National Health Service is soon set to roll out immune-boosting drugs to protect 10 per cent patients who fail to respond to the COVID vaccine, the media reported.
While COVID jabs have proved effective in preventing severe illness, hospitalisation and death among 90 per cent people, scientists believe between five and ten per cent of the fully vaccinated people, could still become severely unwell with COVID.
These are mainly those with weakened immune systems which means their bodies cannot mount a strong defence to the virus.
Administering such people with the additional drugs known as monoclonal antibodies can prevent COVID infection -- even if they're living in a house with someone infected, said the report, quoting a recent study published in 'The New England Journal Of Medicine'. The drugs target the spike protein -- the section of the virus that allows it to bind with healthy cells and help reduce the amount of virus that can enter the body and the likelihood of serious symptomatic COVID. (IANS)